KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Repligen (RGEN) Shares Outstanding (Weighted Average) (2016 - 2025)

Repligen (RGEN) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $56234.0 as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 0.53% to $56234.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $56234.0 through Dec 2025, up 0.53% year-over-year, with the annual reading at $56234.0 for FY2025, 0.53% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $56234.0 at Repligen, roughly flat from $56265.0 in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $56265.0 in Q3 2025, with the low at $54805.0 in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $55619.2, with a median of $55668.0 recorded in 2023.
  • Peak annual rise in Shares Outstanding (Weighted Average) hit 4.68% in 2021, while the deepest fall reached 99.9% in 2021.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $55015.0 in 2021, then grew by 0.81% to $55460.0 in 2022, then grew by 0.47% to $55720.0 in 2023, then increased by 0.39% to $55937.0 in 2024, then grew by 0.53% to $56234.0 in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $56234.0, $56265.0, and $56179.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.